In particular, CLL-MVs can activate the AKT signaling pathway in CLL-BMSCs by inducing the production of vascular endothelial growth factor (VEGF), a survival factor for CLL cells [107]. This evidence concerns the gene VEGFA and B-cell chronic lymphocytic leukemia.